INVO Fertility, Inc. (IVF) Form 10-Q — Jun 22, 2026

INVO Fertility reported total revenue of $2.0 million for the three months ended March 31, 2026, an increase from $1.6 million in the prior year period, driven primarily by growth in clinic revenue. The company recorded a net loss of $5.5 million for the quarter, widening from the prior year's $1.5 million loss from continuing operations, though the prior year included a significant loss from discontinued operations. Management explicitly stated that there is substantial doubt about the company's ability to continue as a going concern for at least one year, citing an accumulated deficit of approximately $96.9 million and the need to raise additional capital to fund operations.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.